Construction method of open-angle glaucoma disease animal model

By inducing necrotizing apoptosis of trabecular reticulocytes in anterior chamber injection in animals, the problems of high intraocular pressure instability and short duration of existing glaucoma models were solved, and a human open angle type was successfully constructed The high intraocular pressure model with glaucoma characteristics achieves the stability of intraocular pressure increase and the simple operation of the model.

CN118923612APending Publication Date: 2024-11-12THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410923704.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-10
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The existing animal models of glaucoma have instability in inducing high intraocular pressure, short duration, and great influence on the anatomic structure of the aquaculture cycle of animals, making it difficult to effectively simulate the chronic intraocular pressure increase process of human primary open-angle glaucoma. .

Method used

Necroptosis of trabecular reticulocytes was induced by anterior chamber injection in SPF grade C57BL/6J mice, SD rats, and Japanese big-eared white rabbits, resulting in increased intraocular pressure and through TonoLab and TonoVet A rebound tonometer was used to measure intraocular pressure, combined with resin sections and hematoxylin-eosin staining to observe the atrial angle and retinal damage, and established a high intraocular pressure model that conforms to the characteristics of human open angle glaucoma.

Benefits of technology

A glaucoma animal model with stable intraocular pressure elevation, long duration and no changes in the anatomic structure of normal ocular aquaculture circulation was successfully constructed, which simulated the opening angle of the anterior angle, impaired trabecular mesh function and optic nerve damage of human open-angle glaucoma. Higher modeling success rate and ease of operation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118923612A_ABST
    Figure CN118923612A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of disease animal models, in particular to a construction method of an open-angle glaucoma disease animal model, starting from the pathogenesis of open-angle glaucoma, IFN-gamma is injected into an anterior chamber to induce necrotic apoptosis of trabecular meshwork cells, so that trabecular meshwork activity inhibition, function impairment and intraocular pressure rise are caused, and the open-angle glaucoma disease animal model is obtained. Further, glaucoma optic nerve change is caused. The pathophysiological change of the eye of the animal model is similar to that of human open-angle glaucoma: the chamber angle is open, the trabecular meshwork function is damaged, the intraocular pressure is increased, and retinal ganglion cells (RGCs) are lost. The preparation of the glaucoma animal model is innovative, has great advantages and feasibility, is high in modeling success rate, short in induction period, obvious and stable in intraocular pressure increase and relatively simple to operate, and the intraocular pressure is increased without blocking a trabecular meshwork or mechanically damaging a normal aqueous humor outflow anatomical structure; the composition is more suitable for pathophysiological changes of primary open-angle glaucoma.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of disease animal models, and in particular to a method for constructing an open-angle glaucoma disease animal model. Background Art

[0002] Glaucoma is a group of diseases characterized by the progressive irreversible death of retinal ganglion cells and visual field loss, which threaten and damage the optic nerve and visual function. It is the main cause of irreversible vision loss worldwide and is expected to reach 111.8 million people by 2040. Among them, primary open-angle glaucoma is the most common type of glaucoma, accounting for about 60-70% of all glaucoma. It is relatively insidious and difficult to diagnose at an early stage. Its main risk factor is the increase in aqueous humor outflow resistance, which leads to pathological increase in intraocular pressure and progressive irreversible death of retinal ganglion cells. 75% of the aqueous humor outflow resistance comes from the trabecular meshwork, which shows that maintaining the normal activity and function of trabecular meshwork cells is crucial to controlling intraocular pressure.

[0003] Since the pathogenesis of glaucoma is very complex, the molecular pathological mechanism of glaucoma is not very clear at present, and it is also difficult to conduct pathological research on humans. In order to further understand the molecular pathological biology of glaucoma and develop better treatment methods, it is necessary to establish clinically relevant animal models. With the improvement of glaucoma induction methods and the improvement of glaucoma damage to the eye measurement and quantification methods, there are many different mechanisms of glaucoma animal models induced, which can reflect the characteristics of pathological and physiological damage changes in human glaucoma. The existing high-pressure glaucoma animal models include: anterior chamber injection of microsphere material model, laser photocoagulation model, episcleral vein hypertonic saline injection model, episcleral vein cauterization model, transgenic model, steroid drug-induced model, etc. However, these methods are not ideal high-pressure models because of their great influence on the anatomical structure of animal aqueous humor circulation, high incidence of corneal endothelial decompensation, aggravated inflammatory response, unstable and short-lasting intraocular pressure increase. In particular, most of the current models will cause acute intraocular pressure increase, which is inconsistent with the pathological process of primary open-angle chronic intraocular pressure increase in humans. Therefore, in order to reveal the pathological damage mechanism of primary open-angle glaucoma in humans and explore new methods for anti-glaucoma treatment, it is very necessary to construct a new glaucoma animal model that is closer to the pathogenesis of human open-angle glaucoma. In view of this, we proposed a method for constructing an animal model of open-angle glaucoma disease. Summary of the invention

[0004] The purpose of the present invention is to provide a method for constructing an open-angle glaucoma disease animal model to solve the problems raised in the above background technology.

[0005] To achieve the above object, the present invention provides the following technical solutions:

[0006] A method for constructing an open-angle glaucoma disease animal model, the method comprising the following steps:

[0007] Step S1: Select SPF-grade C57BL / 6J mice, SD rats, and Japanese large-eared white rabbits as modeling subjects: C57BL / 6J mice are aged 6 to 8 weeks, SD rats are aged 4 to 8 weeks, and Japanese large-eared white rabbits are aged 12 to 14 months;

[0008] Step S2: Establishment of high intraocular pressure model:

[0009] Anesthesia method:

[0010] After weighing the modeling animals, 1% sodium pentobarbital anesthetic was injected intraperitoneally at a dose of 40-50 mg / kg to induce general anesthesia in C57BL / 6J mice and SD rats, and ketamine hydrochloride anesthetic was injected intramuscularly at a dose of 22-44 mg / kg to induce general anesthesia in rabbits. After confirming that the animals were in deep anesthesia, proparacaine hydrochloride eye drops were used for surface anesthesia of the eyes;

[0011] Preparation of IFN-γ injection solution:

[0012] The IFN-γ stock solutions of different species were diluted to 9000 Units / ml, 20000 Units / ml, and 30000 Units / ml using PBS buffer;

[0013] Intracameral injection:

[0014] 1) Mouse / rat

[0015] ① Place the anesthetized mouse / rat on the operating microscope operating table. A temperature-maintaining mat is placed under the operating table to prevent the mouse / rat from cooling down during the operation. With one eye facing upward, use a sterile cotton swab dipped in iodine to disinfect the eyelid margin, trim the eyelashes, and expose the eyeball. Use sterile PBS or ofloxacin antibiotic eye drops to rinse the ocular surface, and then use a dry sterile cotton swab to wipe off the residual liquid and other debris on the ocular surface.

[0016] ②Use micro toothless forceps to fix the eyeball, first use a 34G needle to make a small puncture about 2mm outside the pupil edge and release some aqueous humor, use a micro syringe connected to a 33G needle (range of 10μl) to tilt 25° through the original corneal puncture to inject IFN-γ (mice: 1μl, rats: 3μl), then slowly inject 2μl of air to form a complete bubble in the anterior chamber, after injection, the micro syringe needle stays in the appropriate position in the anterior chamber for 30s, and then slowly withdraws the needle to allow the bubble to self-close the corneal puncture to prevent the injection reagent from reflux; the bubble can be absorbed within a few hours, and the puncture and injection process must be carefully operated to prevent the needle from piercing the iris and anterior capsule of the lens; (the experimental group injected the reagent IFN-γ, and the control group injected the reagent with an equal volume of PBS);

[0017] ③ After the operation, apply ofloxacin antibiotic eye ointment to the eyes to prevent infection, place the mice on an animal temperature maintenance device to maintain body temperature, wait for them to recover naturally, and then put them back into the animal breeding room after recovery;

[0018] ④ Repeat the anterior chamber injection once a week to maintain the anterior chamber IFN-γ concentration;

[0019] 2) Rabbit

[0020] ① Place the anesthetized rabbit directly on the operating table and perform the same disinfection and preparation as for mice / rats;

[0021] ②Use micro toothless forceps or sterile cotton swabs to fix the eyeball, first use a 30G needle to make a puncture at the limbus of the cornea and release some aqueous humor, then use a micro syringe (range of 100μl) connected to a 30G needle to inject IFN-γ (rabbit: 55μl) through the original corneal puncture at an angle of 25°. After injection, the needle stays in the appropriate position in the anterior chamber for 30s, then slowly withdraws the needle, and presses and closes the puncture with a sterile cotton swab to prevent the injection reagent from flowing back. The remaining operations are the same as those for mice / rats.

[0022] Intraocular pressure measurement:

[0023] 1) Mouse / rat

[0024] ① Gas inhalation anesthesia: Before each intraocular pressure measurement, mice / rats were anesthetized with 2-4% isoflurane mixed with 95% oxygen, and placed in a gas anesthesia machine for 3-5 minutes. The anesthesia effect was determined by squeezing the toes of the mice / rats or observing the blinking reflex to determine whether they lost consciousness. At the same time, proparacaine hydrochloride eye drops were used for surface anesthesia of the eyes;

[0025] ②Use of TonoLab rebound tonometer: TonoLab rebound tonometer has two calibration modes for measuring mice and rats (Π=mouse, r=rat). When measuring, the rebound needle should be aimed at the center of the mouse / rat cornea, and the tonometer should be kept in a horizontal position and perpendicular to the surface of the mouse / rat cornea; Note that when holding the mouse / rat during the measurement, try to avoid applying pressure to its neck and eye socket, otherwise it will artificially cause an increase in intraocular pressure; After the mouse / rat is anesthetized by inhalation, the intraocular pressure is measured using the TonoLab rebound tonometer, and all intraocular pressure measurements are measured by the same operator in the same time period; TonoLab rebound tonometer can automatically calculate a complete measurement value by removing the highest and lowest values ​​of 6 consecutive measurements through the built-in software, and complete 5 complete measurements within 2 minutes after the mouse / rat loses consciousness, and then take the average of the 5 complete measurements as the final intraocular pressure value;

[0026] ③ Time point of intraocular pressure measurement: The basic intraocular pressure measurement is before the first anterior chamber injection. The recommended measurement time is 8-10 am. The intraocular pressure is measured every other day after the anterior chamber injection. The anterior chamber injection is repeated every week during this period. After 4 weeks of monitoring, if the intraocular pressure rises steadily, the intraocular pressure can be monitored every other week. The modeling time lasts for 12 weeks.

[0027] 2) Rabbit

[0028] ① The intraocular pressure of the rabbit can be measured under topical anesthesia, and the rabbit box can be used to fix it for easy operation;

[0029] ②Use of TonoVet rebound tonometer: TonoVet rebound tonometer is suitable for rabbits, cats, dogs, etc., and does not require manual calibration. When measuring, aim the rebound needle at the center of the rabbit cornea and keep the tonometer in a horizontal position while being perpendicular to the rabbit corneal surface. Note that if a rabbit box is used to fix it during the measurement, it should be avoided from getting stuck, otherwise it may cause increased intraocular pressure. The rest of the measurement process is the same as that of mice / rats.

[0030] Step S3: After the high intraocular pressure model is successfully established, the eyeballs of the animals are taken to observe the angle opening, trabecular meshwork damage and retinal damage. After a group of experimental animals are killed at the end of the 4th week, the 8th week and the 12th week after the first intracameral injection, the eyeballs are taken for resin sectioning and hematoxylin-eosin staining (HE staining) to observe the angle opening, trabecular meshwork and retinal damage; after the isolated eyeballs are fixed, embedded, sectioned (mainly including angle trabecular meshwork sections and retinal sections), and HE staining, optical microscope is used to take pictures and observe to understand the angle opening, trabecular meshwork damage and retinal damage;

[0031] Step S4: After the high intraocular pressure model is successfully established, the glaucomatous optic nerve damage is evaluated:

[0032] A group of experimental animals were selected at the end of the 4th, 8th and 12th week after the first intracameral injection. Retinal flat-mounts were taken after perfusion and retinal ganglion cells (RGCs) were counted. The loss of RGCs was evaluated to understand the optic nerve damage in the high intraocular pressure animal model and verify whether it met the characteristic retinal damage of glaucoma.

[0033] Step S5: Set up an intraocular pressure-lowering control group, and evaluate retinal damage after excluding factors affecting intraocular pressure to verify the effect of IFN-γ on intraocular pressure alone:

[0034] The experimental animals were given anterior chamber injection of IFN-γ and intervention with hypotensive eye drops at the same time. 0.5% timolol maleate eye drops were used twice a day, 1 drop was administered through the conjunctival sac each time, at 9 am and 6 pm respectively, for 12 weeks. The intraocular pressure monitoring method and time point were the same as before, and the intraocular pressure was controlled at the baseline intraocular pressure, or the intraocular pressure fluctuation range was roughly the same as the anterior chamber injection of PBS control group to exclude the direct damage of IFN-γ to retinal ganglion cells. From the same day of the first anterior chamber injection of IFN-γ, the animals were given hypotensive drug intervention, respectively. A group of experimental animals were killed at the end of the 4th week, the 8th week, and the 12th week. The eyeballs were taken for resin sectioning and hematoxylin-eosin staining (HE staining), retinal flat mounts, and RGCs counting (same method as before), to evaluate the full-thickness retinal damage and RGCs loss rate. The results were compared with the group that received intracameral injection of IFN-γ without intraocular pressure-lowering drug intervention. After excluding the factor of increased intraocular pressure caused by IFN-γ, the RGCs loss rate was significantly reduced, and no damage was found in the full-thickness retina, thereby verifying the effect of IFN-γ alone on intraocular pressure.

[0035] Preferably, in step S3, taking mice as an example, the specific steps are as follows:

[0036] ① Isolation of the retina after perfusion of mice:

[0037] 1) Induce general anesthesia in mice by intraperitoneal injection of 1% sodium pentobarbital at a dose of 40-50 mg / kg, fix the mice on a foam board with needles (insert the limbs with needles), and spray the mouse hair with 75% alcohol;

[0038] 2) Use forceps to lift the skin at the xiphoid process of the mouse, and use ophthalmic scissors to cut the skin and ribs of the chest to expose the heart and liver;

[0039] 3) Use forceps to hold the mouse's heart apex, connect a 10ml needle to a syringe that absorbs 10ml of saline, and carefully insert it into the mouse's heart apex (be careful not to insert the needle too deep to prevent the liquid from being infused into the lungs). First, infuse a small amount of saline. After cutting the right atrial appendage with scissors in the left hand, infuse all the remaining saline. After the blood is drained, the limbs, liver, and tongue will turn white.

[0040] 4) Keep the needle in the apex of the heart, remove the syringe, replace it with a syringe filled with 10ml 4% paraformaldehyde, and continue perfusion. When the paraformaldehyde flows to the brain, the mouse tail may have a slight reflex (sometimes there may be no reflex). At this time, the perfusion rate can be reduced to make the fixation more complete; (Fixation principle: paraformaldehyde can cross-link proteins);

[0041] 5) Place the fixed mouse under a microscope and use forceps to remove the eyeball, being careful not to break it;

[0042] 6) The intact eyeball was placed in an EP tube containing 4% paraformaldehyde and fixed at room temperature for 1 hour;

[0043] 7) After puncturing the eyeball with a PP needle, use trabecular scissors to cut away the cornea and iris along the rupture, retain the lens, and continue to place it in an EP tube containing 4% paraformaldehyde for fixation at room temperature for 2-4 hours;

[0044] 8) Remove the lens, hold the edge of the choroid with two forceps, carefully tear it apart to separate the choroid and retina, and continue to place it in an EP tube containing 4% paraformaldehyde at 4 degrees for fixation overnight;

[0045] ② Retinal flat mount and RGCs staining:

[0046] 1) Place the retina in a 24-well plate and wash with PBST for 15 min x 3 times (shaking gently);

[0047] 2) 50% methanol for 10 min (light shaking);

[0048] 3) 100% methanol for 10 min (light shaking);

[0049] 4) Wash with PBST for 15 min x 3 (shake gently);

[0050] 5) Remove the retina, place it on a glass slide, and cut it into a four-leaf clover shape with a blade, so that it can be laid flat on the glass slide;

[0051] 6) Blocking buffer (10 ml PBS + 1% BSA (0.1 g) + 0.5% Triton X-100 (50 ul)): room temperature, 60 min (gentle shaking);

[0052] 7) Primary antibody RBPMS at 4°C overnight (protected from light);

[0053] 8) Wash with PBST for 20 min x 4 (shake gently);

[0054] 9) Secondary antibody at room temperature for 2 hours (protected from light);

[0055] 10) Clip the retina and carefully flatten it on a glass slide. Add 1 drop of PBST to each retina to prevent it from drying. Hold your right hand with one finger and use tweezers in your right hand to remove iris fragments and other debris on the retina. Then use paper to absorb excess liquid from the retina.

[0056] 11) Add anti-fluorescence quenching mounting medium, cover with coverslip, seal with nail polish and let dry, place paper on the surface of the slide, use a tip box to press a proper amount of water on the omentum for 0.5h, and store in a wet box;

[0057] ③RGCs counting:

[0058] Fluorescence microscopy was used to image, photograph and count RGCs. The mouse retinal flat mounts were divided into four quadrants: dorsal, ventral, nasal, and temporal. Two locations in each quadrant were selected for photography. ImageJ and ZEN image analysis software were used to count the RGCs in the photos, and the average count value was taken. The percentage of RGCs lost in the eyes injected with IFN-γ in the anterior chamber was calculated by comparing with the PBS control group.

[0059] Preferably, in step S1, the animals are raised in a standard environment, with free access to water and food, and the experiment begins after one week of adaptive feeding. The raising and operation strictly follow the ethical requirements of scientific research animals.

[0060] Preferably, in step S2, the intraocular pressure is as follows:

[0061] ① The basal intraocular pressure of mice before intracameral injection was 9.5±0.5 mmHg;

[0062] ② After intracameral injection of IFN-γ, intraocular pressure gradually increases:

[0063] C57BL / 6J mice were injected with IFN-γ (9000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice was monitored and it was significantly increased compared with the intraocular pressure of the control group from the 4th day after the first intracameral injection, which was statistically significant (P<0.05). It continued to rise steadily and reached a peak intraocular pressure level of 30.76±2.55mmHg about 35 days after modeling. The intraocular pressure was stably maintained around the peak value during the observation period of 35 to 90 days, which is a relatively ideal model of high intraocular pressure.

[0064] C57BL / 6J mice were injected with IFN-γ (20000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice increased significantly from the second day after the first intracameral injection compared with the control group, with a statistically significant difference (P<0.05). The intraocular pressure reached a peak of 29.53±1.11mmHg on the 42nd day. The subsequent intraocular pressure values ​​were maintained around the peak value, which is a relatively ideal model of high intraocular pressure.

[0065] C57BL / 6J mice were injected with IFN-γ (30000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice was monitored and the intraocular pressure level could directly reach 23.84±0.41mmHg from the second day after the first intracameral injection. Compared with the intraocular pressure of the control group, it was significantly increased with statistical significance (P<0.0001). The intraocular pressure was stable at a high value from the second to the 90th day, and the highest value could reach 29.88±1.54mmHg, which is a relatively ideal model of high intraocular pressure.

[0066] Openness of chamber angle and damage of trabecular meshwork:

[0067] One group of mice were killed at the 4th, 8th and 12th week after the first intracameral injection, and the mouse eyeballs were taken for resin sectioning and hematoxylin-eosin staining (HE staining). Observation under an optical microscope showed that the chamber angle was open all around, which was consistent with the anatomical characteristics of open-angle glaucoma, and no obvious mechanical damage was found in the trabecular meshwork.

[0068] Preferably, in step S4, the full-thickness retinal damage is as follows:

[0069] At the end of the 4th, 8th, and 12th week after the first intracameral injection, mice were killed and their eyeballs were sliced ​​with resin and stained with hematoxylin-eosin (HE). Observation under an optical microscope revealed no obvious inflammatory damage in the entire retinal layer.

[0070] The retinal ganglion cell counts were as follows:

[0071] RGCs can be specifically marked by tissue immunofluorescence staining. A group of mice were selected at the end of the 4th, 8th and 12th week after the first intracameral injection. After perfusion, the retinal flat sections of both eyes were taken to count the retinal RGCs. The results showed that after 12 weeks of modeling, the number of RGCs in the intracameral injection of IFN-γ group was significantly reduced compared with the control group (P<0.05), indicating that the intracameral injection of IFN-γ can effectively induce increased intraocular pressure and glaucomatous optic nerve damage in mice.

[0072] Preferably, in step S2, the direct effect of IFN-γ on the retina is evaluated after intravitreal injection:

[0073] The experimental animals were injected with IFN-γ and PBS into the vitreous to evaluate the intraocular pressure and the damage to the whole retina. The intravitreal injection was performed on the basis of pupil dilation. Because the mouse / rat lens occupies a large volume in the eye, attention should be paid to the inclination angle of the needle tip to avoid damaging the lens, retina and other intraocular tissues. To avoid acute increase in intraocular pressure, anterior chamber puncture can be performed before vitreous injection to release a small amount of aqueous humor. After injection, the needle stays in the vitreous for about 30 seconds, and then slowly withdraws the needle. When withdrawing the needle, the conjunctival incision can be closed with micro forceps to prevent leakage. The injection cycle is 12 weeks. One group of experimental animals was killed at the end of the 4th, 8th and 12th week, respectively. The eyeballs were sliced ​​and stained with HE (the method is the same as before) to evaluate the damage to the whole retina caused by the direct action of IFN-γ on the retina.

[0074] Compared with the prior art, the present invention has the following beneficial effects:

[0075] 1. The method for constructing the animal model of open-angle glaucoma disease is different from the existing method for constructing glaucoma animal models. Starting from the pathogenic mechanism of glaucoma, the present invention induces the necroptosis mechanism of trabecular meshwork cells by injecting IFN-γ into the anterior chamber, thereby causing the inhibition of trabecular meshwork activity and impaired function, causing increased intraocular pressure, and further leading to glaucomatous optic nerve changes. Its ocular pathophysiological changes are similar to those of human open-angle glaucoma: open angle, impaired trabecular meshwork function, increased intraocular pressure, and loss of RGCs (positively correlated with the duration of increased intraocular pressure). The preparation of the glaucoma animal model is innovative, with a high modeling success rate, a short cycle, a significant and stable increase in intraocular pressure, a relatively simple operation, and does not change the normal anatomical structure of the aqueous humor circulation, etc., and has great advantages and feasibility.

[0076] 2. The method for constructing an animal model of open-angle glaucoma disease simulates the ocular characteristics of human open-angle glaucoma, establishes a glaucoma animal model with a short induction period, stable increase in intraocular pressure, and a high modeling success rate, and constructs a new open-angle glaucoma animal model that does not increase intraocular pressure by blocking the trabecular meshwork or mechanically damaging the anatomical structure of aqueous humor outflow, which is more in line with the pathophysiological changes of primary open-angle glaucoma. BRIEF DESCRIPTION OF THE DRAWINGS

[0077] Figure 1 This is a graph showing changes in intraocular pressure after 12 weeks of intracameral injection of MouseIFN-γ 9000U / ml or PBS into mice of the present invention;

[0078] Figure 2 This is a graph showing changes in intraocular pressure after 12 weeks of intracameral injection of MouseIFN-γ 20000U / ml or PBS in mice of the present invention;

[0079] Figure 3 This is a graph showing changes in intraocular pressure after 12 weeks of intracameral injection of MouseIFN-γ 30000U / ml or PBS in mice of the present invention;

[0080] Figure 4 This is a diagram showing the death of RGCs in mice injected with MouseIFN-γ 9000U / ml or PBS into the anterior chamber for 12 weeks in the present invention;

[0081] Figure 5 This is a diagram showing the death of RGCs in mice injected with MouseIFN-γ 20000U / ml or PBS into the anterior chamber for 12 weeks in the present invention;

[0082] Figure 6 This is a diagram showing the death of RGCs in mice injected with MouseIFN-γ 30000U / ml or PBS into the anterior chamber for 12 weeks in the present invention;

[0083] Figure 7 This is the experimental instrument table of the present invention;

[0084] Figure 8 This is a table of experimental reagents for the present invention. DETAILED DESCRIPTION

[0085] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0086] See also Figure 1-Figure 8 As shown, a technical solution provided by the present invention is:

[0087] A method for constructing an open-angle glaucoma disease animal model, the method comprising the following steps:

[0088] Step S1: Select SPF-grade C57BL / 6J mice, SD rats, and Japanese large-eared white rabbits as modeling subjects: C57BL / 6J mice are aged 6 to 8 weeks, SD rats are aged 4 to 8 weeks, and Japanese large-eared white rabbits are aged 12 to 14 months;

[0089] Step S2: Establishment of high intraocular pressure model:

[0090] Anesthesia method:

[0091] After weighing the modeling animals, 1% sodium pentobarbital anesthetic was injected intraperitoneally at a dose of 40-50 mg / kg to induce general anesthesia in C57BL / 6J mice and SD rats, and ketamine hydrochloride anesthetic was injected intramuscularly at a dose of 22-44 mg / kg to induce general anesthesia in rabbits. After confirming that the animals were in deep anesthesia, proparacaine hydrochloride eye drops were used for surface anesthesia of the eyes;

[0092] Preparation of IFN-γ injection solution:

[0093] The IFN-γ stock solutions of different species were diluted to 9000 Units / ml, 20000 Units / ml, and 30000 Units / ml using PBS buffer;

[0094] Intracameral injection:

[0095] 1) Mouse / rat

[0096] ① Place the anesthetized mouse / rat on the operating microscope operating table. A temperature-maintaining mat is placed under the operating table to prevent the mouse / rat from cooling down during the operation. With one eye facing upward, use a sterile cotton swab dipped in iodine to disinfect the eyelid margin, trim the eyelashes, and expose the eyeball. Use sterile PBS or ofloxacin antibiotic eye drops to rinse the ocular surface, and then use a dry sterile cotton swab to wipe off the residual liquid and other debris on the ocular surface.

[0097] ②Use micro toothless forceps to fix the eyeball, first use a 34G needle to make a small puncture about 2mm outside the pupil edge and release some aqueous humor, use a micro syringe connected to a 33G needle (range of 10μl) to tilt 25° through the original corneal puncture to inject IFN-γ (mice: 1μl, rats: 3μl), then slowly inject 2μl of air to form a complete bubble in the anterior chamber, after injection, the micro syringe needle stays in the appropriate position in the anterior chamber for 30s, and then slowly withdraws the needle to allow the bubble to self-close the corneal puncture to prevent the injection reagent from reflux; the bubble can be absorbed within a few hours, and the puncture and injection process must be carefully operated to prevent the needle from piercing the iris and anterior capsule of the lens; (the experimental group injected the reagent IFN-γ, and the control group injected the reagent with an equal volume of PBS);

[0098] ③ After the operation, apply ofloxacin antibiotic eye ointment to the eyes to prevent infection, place the mice on an animal temperature maintenance device to maintain body temperature, wait for them to recover naturally, and then put them back into the animal breeding room after recovery;

[0099] ④ Repeat the anterior chamber injection once a week to maintain the anterior chamber IFN-γ concentration;

[0100] 2) Rabbit

[0101] ① Place the anesthetized rabbit directly on the operating table and perform the same disinfection and preparation as for mice / rats;

[0102] ②Use micro toothless forceps or sterile cotton swabs to fix the eyeball, first use a 30G needle to make a puncture at the limbus of the cornea and release some aqueous humor, then use a micro syringe (range of 100μl) connected to a 30G needle to inject IFN-γ (rabbit: 55μl) through the original corneal puncture at an angle of 25°. After injection, the needle stays in the appropriate position in the anterior chamber for 30s, then slowly withdraws the needle, and presses and closes the puncture with a sterile cotton swab to prevent the injection reagent from flowing back. The remaining operations are the same as those for mice / rats.

[0103] Intraocular pressure measurement:

[0104] 1) Mouse / rat

[0105] ① Gas inhalation anesthesia: Before each intraocular pressure measurement, mice / rats were anesthetized with 2-4% isoflurane mixed with 95% oxygen, and placed in a gas anesthesia machine for 3-5 minutes. The anesthesia effect was determined by squeezing the toes of the mice / rats or observing the blinking reflex to determine whether they lost consciousness. At the same time, proparacaine hydrochloride eye drops were used for surface anesthesia of the eyes;

[0106] ②Use of TonoLab rebound tonometer: TonoLab rebound tonometer has two calibration modes for measuring mice and rats (Π=mouse, r=rat). When measuring, the rebound needle should be aimed at the center of the mouse / rat cornea, and the tonometer should be kept in a horizontal position and perpendicular to the surface of the mouse / rat cornea; Note that when holding the mouse / rat during the measurement, try to avoid applying pressure to its neck and eye socket, otherwise it will artificially cause an increase in intraocular pressure; After the mouse / rat is anesthetized by inhalation, the intraocular pressure is measured using the TonoLab rebound tonometer, and all intraocular pressure measurements are measured by the same operator in the same time period; TonoLab rebound tonometer can automatically calculate a complete measurement value by removing the highest and lowest values ​​of 6 consecutive measurements through the built-in software, and complete 5 complete measurements within 2 minutes after the mouse / rat loses consciousness, and then take the average of the 5 complete measurements as the final intraocular pressure value;

[0107] ③ Time point of intraocular pressure measurement: The basic intraocular pressure measurement is before the first anterior chamber injection. The recommended measurement time is 8-10 am. The intraocular pressure is measured every other day after the anterior chamber injection. The anterior chamber injection is repeated every week during this period. After 4 weeks of monitoring, if the intraocular pressure rises steadily, the intraocular pressure can be monitored every other week. The modeling time lasts for 12 weeks.

[0108] 2) Rabbit

[0109] ① The intraocular pressure of the rabbit can be measured under topical anesthesia, and the rabbit box can be used to fix it for easy operation;

[0110] ②Use of TonoVet rebound tonometer: TonoVet rebound tonometer is suitable for rabbits, cats, dogs, etc., and does not require manual calibration. When measuring, aim the rebound needle at the center of the rabbit cornea and keep the tonometer in a horizontal position while being perpendicular to the rabbit corneal surface. Note that if a rabbit box is used to fix it during the measurement, it should be avoided from getting stuck, otherwise it may cause increased intraocular pressure. The rest of the measurement process is the same as that of mice / rats.

[0111] Step S3: After the high intraocular pressure model is successfully established, the eyeballs of the animals are taken to observe the angle opening, trabecular meshwork damage and retinal damage. After a group of experimental animals are killed at the end of the 4th week, the 8th week and the 12th week after the first intracameral injection, the eyeballs are taken for resin sectioning and hematoxylin-eosin staining (HE staining) to observe the angle opening, trabecular meshwork and retinal damage; after the isolated eyeballs are fixed, embedded, sectioned (mainly including angle trabecular meshwork sections and retinal sections), and HE staining, optical microscope is used to take pictures and observe to understand the angle opening, trabecular meshwork damage and retinal damage;

[0112] Step S4: After the high intraocular pressure model is successfully established, the glaucomatous optic nerve damage is evaluated:

[0113] A group of experimental animals were selected at the end of the 4th week, the 8th week, and the 12th week after the first intracameral injection. Retinal flat-mounts were taken after perfusion and RGCs were counted. The loss of RGCs was evaluated to understand the optic nerve damage in the high intraocular pressure animal model and to verify whether it met the characteristic retinal damage of glaucoma.

[0114] Step S5: Set up an intraocular pressure-lowering control group, and evaluate retinal damage after excluding factors affecting intraocular pressure to verify the effect of IFN-γ on intraocular pressure alone:

[0115] The experimental animals were given anterior chamber injection of IFN-γ and intervention with hypotensive eye drops. 0.5% timolol maleate eye drops were used twice a day, 1 drop was administered through the conjunctival sac each time, at 9 am and 6 pm respectively, for 12 weeks. The intraocular pressure monitoring method and time point were the same as before (3.4), and the intraocular pressure was controlled at the baseline intraocular pressure, or the intraocular pressure fluctuation range was roughly the same as the intraocular injection of PBS control group, to exclude the direct damage of IFN-γ to retinal ganglion cells; from the same day of the first intracameral injection of IFN-γ, the animals were given hypotensive drugs. A group of experimental animals were killed at the end of the 4th week, the 8th week, and the 12th week respectively. The eyeballs were taken for resin sectioning and hematoxylin-eosin staining (HE staining), retinal flat mounts and RGCs counting (same method as before), to evaluate the full-thickness retinal damage and RGCs loss rate. The results were compared with the group that received intracameral injection of IFN-γ without intraocular pressure-lowering drug intervention. After excluding the factor of increased intraocular pressure caused by IFN-γ, the RGCs loss rate was significantly reduced, and no damage was found in the full-thickness retina, thereby verifying the effect of IFN-γ alone on intraocular pressure.

[0116] In this embodiment, in step S3, taking mice as an example, the specific steps are as follows:

[0117] ① Isolation of the retina after perfusion of mice:

[0118] 1) Induce general anesthesia in mice by intraperitoneal injection of 1% sodium pentobarbital at a dose of 40-50 mg / kg, fix the mice on a foam board with needles (insert the limbs with needles), and spray the mouse hair with 75% alcohol;

[0119] 2) Use forceps to lift the skin at the xiphoid process of the mouse, and use ophthalmic scissors to cut the skin and ribs of the chest to expose the heart and liver;

[0120] 3) Use forceps to hold the mouse's heart apex, connect a 10ml needle to a syringe that absorbs 10ml of saline, and carefully insert it into the mouse's heart apex (be careful not to insert the needle too deep to prevent the liquid from being infused into the lungs). First, infuse a small amount of saline. After cutting the right atrial appendage with scissors in the left hand, infuse all the remaining saline. After the blood is drained, the limbs, liver, and tongue will turn white.

[0121] 4) Keep the needle in the apex of the heart, remove the syringe, replace it with a syringe filled with 10ml 4% paraformaldehyde, and continue perfusion. When the paraformaldehyde flows to the brain, the mouse tail may have a slight reflex (sometimes there may be no reflex). At this time, the perfusion rate can be reduced to make the fixation more complete; (Fixation principle: paraformaldehyde can cross-link proteins);

[0122] 5) Place the fixed mouse under a microscope and use forceps to remove the eyeball, being careful not to break it;

[0123] 6) The intact eyeball was placed in an EP tube containing 4% paraformaldehyde and fixed at room temperature for 1 hour;

[0124] 7) After puncturing the eyeball with a PP needle, use trabecular scissors to cut away the cornea and iris along the rupture, retain the lens, and continue to place it in an EP tube containing 4% paraformaldehyde for fixation at room temperature for 2-4 hours;

[0125] 8) Remove the lens, hold the edge of the choroid with two forceps, carefully tear it apart to separate the choroid and retina, and continue to place it in an EP tube containing 4% paraformaldehyde at 4 degrees for fixation overnight;

[0126] ② Retinal flat mount and RGCs staining:

[0127] 1) Place the retina in a 24-well plate and wash with PBST for 15 min x 3 times (shaking gently);

[0128] 2) 50% methanol for 10 min (light shaking);

[0129] 3) 100% methanol for 10 min (light shaking);

[0130] 4) Wash with PBST for 15 min x 3 (shake gently);

[0131] 5) Remove the retina, place it on a glass slide, and cut it into a four-leaf clover shape with a blade, so that it can be laid flat on the glass slide;

[0132] 6) Blocking buffer (10 ml PBS + 1% BSA (0.1 g) + 0.5% Triton X-100 (50 ul)): room temperature, 60 min (gentle shaking);

[0133] 7) Primary antibody RBPMS at 4°C overnight (protected from light);

[0134] 8) Wash with PBST for 20 min x 4 (shake gently);

[0135] 9) Secondary antibody at room temperature for 2 hours (protected from light);

[0136] 10) Clip the retina and carefully flatten it on a glass slide. Add 1 drop of PBST to each retina to prevent it from drying. Hold your right hand with one finger and use tweezers in your right hand to remove iris fragments and other debris on the retina. Then use paper to absorb excess liquid from the retina.

[0137] 11) Add anti-fluorescence quenching mounting medium, cover with coverslip, seal with nail polish and let dry, place paper on the surface of the slide, use a tip box to press a proper amount of water on the omentum for 0.5h, and store in a wet box;

[0138] ③RGCs counting:

[0139] Fluorescence microscopy was used to image, photograph and count RGCs. The mouse retinal flat mounts were divided into four quadrants: dorsal, ventral, nasal, and temporal. Two locations in each quadrant were selected for photography. ImageJ and ZEN image analysis software were used to count the RGCs in the photos, and the average count value was taken. The percentage of RGCs lost in the eyes injected with IFN-γ in the anterior chamber was calculated by comparing with the PBS control group.

[0140] In this embodiment, in step S1, the animals are kept in a standard environment, with free access to water and food, and the experiment begins after one week of adaptive feeding. The feeding and operation strictly comply with the ethical requirements of scientific research animals.

[0141] In this embodiment, in step S2, the intraocular pressure is as follows:

[0142] ① The basal intraocular pressure of mice before intracameral injection was 9.5±0.5 mmHg;

[0143] ② After intracameral injection of IFN-γ, intraocular pressure gradually increases:

[0144] C57BL / 6J mice were injected with IFN-γ (9000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice was monitored and it was significantly increased compared with the intraocular pressure of the control group from the 4th day after the first intracameral injection, which was statistically significant (P<0.05). It continued to rise steadily and reached a peak intraocular pressure level of 30.76±2.55mmHg about 35 days after modeling. The intraocular pressure was stably maintained around the peak value during the observation period of 35 to 90 days, which is a relatively ideal model of high intraocular pressure.

[0145] C57BL / 6J mice were injected with IFN-γ (20000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice increased significantly from the second day after the first intracameral injection compared with the control group, with a statistically significant difference (P<0.05). The intraocular pressure reached a peak of 29.53±1.11mmHg on the 42nd day. The subsequent intraocular pressure values ​​were maintained around the peak value, which is a relatively ideal model of high intraocular pressure.

[0146] C57BL / 6J mice were injected with IFN-γ (30000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice was monitored and the intraocular pressure level could directly reach 23.84±0.41mmHg from the second day after the first intracameral injection. Compared with the intraocular pressure of the control group, it was significantly increased with statistical significance (P<0.0001). The intraocular pressure was stable at a high value from the second to the 90th day, and the highest value could reach 29.88±1.54mmHg, which is a relatively ideal model of high intraocular pressure.

[0147] Openness of chamber angle and damage of trabecular meshwork:

[0148] One group of mice were killed at the 4th, 8th and 12th week after the first intracameral injection, and the mouse eyeballs were taken for resin sectioning and hematoxylin-eosin staining (HE staining). Observation under an optical microscope showed that the chamber angle was open all around, which was consistent with the anatomical characteristics of open-angle glaucoma, and no obvious mechanical damage was found in the trabecular meshwork.

[0149] In this embodiment, in step S4, the full-thickness retinal damage is as follows:

[0150] At the end of the 4th, 8th, and 12th week after the first intracameral injection, mice were killed and their eyeballs were sliced ​​with resin and stained with hematoxylin-eosin (HE). Observation under an optical microscope revealed no obvious inflammatory damage in the entire retinal layer.

[0151] The retinal ganglion cell counts were as follows:

[0152] RGCs can be specifically marked by tissue immunofluorescence staining. A group of mice were selected at the end of the 4th, 8th and 12th week after the first intracameral injection. After perfusion, the retinal flat sections of both eyes were taken to count the retinal RGCs. The results showed that after 12 weeks of modeling, the number of RGCs in the intracameral injection of IFN-γ group was significantly reduced compared with the control group (P<0.05), indicating that the intracameral injection of IFN-γ can effectively induce increased intraocular pressure and glaucomatous optic nerve damage in mice.

[0153] In this embodiment, in step S2, IFN-γ is injected into the vitreous cavity to evaluate its direct effect on the retina:

[0154] The experimental animals were injected with IFN-γ and PBS into the vitreous to evaluate the intraocular pressure and the damage to the whole retina. The intravitreal injection was performed on the basis of pupil dilation. Because the mouse / rat lens occupies a large volume in the eye, attention should be paid to the inclination angle of the needle tip to avoid damaging the lens, retina and other intraocular tissues. To avoid acute increase in intraocular pressure, anterior chamber puncture can be performed before vitreous injection to release a small amount of aqueous humor. After injection, the needle stays in the vitreous for about 30 seconds, and then slowly withdraws the needle. When withdrawing the needle, the conjunctival incision can be closed with micro forceps to prevent leakage. The injection cycle is 12 weeks. One group of experimental animals was killed at the end of the 4th, 8th and 12th week, respectively. The eyeballs were sliced ​​and stained with HE (the method is the same as before) to evaluate the damage to the whole retina caused by the direct action of IFN-γ on the retina.

[0155] 3. The method for constructing an open-angle glaucoma disease animal model of this embodiment, when used, is different from the existing glaucoma animal model construction method. Starting from the pathogenesis of glaucoma, the present invention induces the necroptosis mechanism of trabecular meshwork cells by injecting IFN-γ into the anterior chamber, thereby causing the inhibition of trabecular meshwork activity and impaired function, causing increased intraocular pressure, and further leading to glaucomatous optic nerve changes. Its ocular pathophysiological changes are similar to those of human open-angle glaucoma: open angle, impaired trabecular meshwork function, increased intraocular pressure, and loss of RGCs (positively correlated with the duration of increased intraocular pressure). The preparation of this glaucoma animal model is innovative, with the characteristics of high modeling success rate, short cycle, obvious and stable increase in intraocular pressure, relatively simple operation, and no change in the normal anatomical structure of the aqueous humor circulation. It has great advantages and feasibility, simulates the ocular characteristics of human open-angle glaucoma, establishes a glaucoma animal model with a short induction cycle, stable increase in intraocular pressure, and high modeling success rate, and constructs a new open-angle glaucoma animal model that does not increase intraocular pressure by blocking the trabecular meshwork or mechanically damaging the anatomical structure of aqueous humor outflow, which is more in line with the pathophysiological changes of primary open-angle glaucoma.

[0156] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited by the above embodiments. The above embodiments and descriptions are only preferred examples of the present invention and are not intended to limit the present invention. Without departing from the spirit and scope of the present invention, the present invention may have various changes and improvements, which fall within the scope of the present invention. The scope of protection of the present invention is defined by the attached claims and their equivalents.

Claims

1. A method for constructing an animal model of open-angle glaucoma disease, characterized in that: The method comprises the following steps: Step S1: Select SPF-grade C57BL / 6J mice, SD rats, and Japanese large-eared white rabbits as modeling subjects: C57BL / 6J mice are aged 6 to 8 weeks, SD rats are aged 4 to 8 weeks, and Japanese large-eared white rabbits are aged 12 to 14 months; Step S2: Establishment of high intraocular pressure model: Anesthesia method: After weighing the modeling animals, 1% sodium pentobarbital anesthetic was injected intraperitoneally at a dose of 40-50 mg / kg to induce general anesthesia in C57BL / 6J mice and SD rats, and ketamine hydrochloride anesthetic was injected intramuscularly at a dose of 22-44 mg / kg to induce general anesthesia in rabbits. After confirming that the animals were in deep anesthesia, proparacaine hydrochloride eye drops were used for surface anesthesia of the eyes; Preparation of IFN-γ injection solution: The IFN-γ stock solutions of different species were diluted to 9000 Units / ml, 20000 Units / ml, and 30000 Units / ml using PBS buffer; Intracameral injection: 1) Mouse / rat ① Place the anesthetized mouse / rat on the operating microscope operating table. A temperature-maintaining mat is placed under the operating table to prevent the mouse / rat from cooling down during the operation. With one eye facing upward, use a sterile cotton swab dipped in iodine to disinfect the eyelid margin, trim the eyelashes, and expose the eyeball. Use sterile PBS or ofloxacin antibiotic eye drops to rinse the ocular surface, and then use a dry sterile cotton swab to wipe off the residual liquid and other debris on the ocular surface. ②Use micro toothless forceps to fix the eyeball, first use a 34G needle to make a small puncture about 2mm outside the pupil edge and release some aqueous humor, use a micro syringe connected to a 33G needle (range of 10μl) to tilt 25° through the original corneal puncture to inject IFN-γ (mice: 1μl, rats: 3μl), then slowly inject 2μl of air to form a complete bubble in the anterior chamber, after injection, the micro syringe needle stays in the appropriate position in the anterior chamber for 30s, and then slowly withdraws the needle to allow the bubble to self-close the corneal puncture to prevent the injection reagent from reflux; the bubble can be absorbed within a few hours, and the puncture and injection process must be carefully operated to prevent the needle from piercing the iris and anterior capsule of the lens; (the experimental group injected the reagent IFN-γ, and the control group injected the reagent with an equal volume of PBS); ③ After the operation, apply ofloxacin antibiotic eye ointment to the eyes to prevent infection, place the mice on an animal temperature maintenance device to maintain body temperature, wait for them to recover naturally, and then put them back into the animal breeding room after recovery; ④ Repeat the anterior chamber injection once a week to maintain the anterior chamber IFN-γ concentration; 2) Rabbit ① Place the anesthetized rabbit directly on the operating table and perform the same disinfection and preparation as for mice / rats; ②Use micro toothless forceps or sterile cotton swabs to fix the eyeball, first use a 30G needle to make a puncture at the limbus of the cornea and release some aqueous humor, then use a micro syringe (range of 100μl) connected to a 30G needle to inject IFN-γ (rabbit: 55μl) through the original corneal puncture at an angle of 25°. After injection, the needle stays in the appropriate position in the anterior chamber for 30s, then slowly withdraws the needle, and presses and closes the puncture with a sterile cotton swab to prevent the injection reagent from flowing back. The remaining operations are the same as those for mice / rats. Intraocular pressure measurement: 1) Mouse / rat ① Gas inhalation anesthesia: Before each intraocular pressure measurement, mice / rats were anesthetized with 2-4% isoflurane mixed with 95% oxygen, and placed in a gas anesthesia machine for 3-5 minutes. The anesthesia effect was determined by squeezing the toes of the mice / rats or observing the blinking reflex to determine whether they lost consciousness. At the same time, proparacaine hydrochloride eye drops were used for surface anesthesia of the eyes; ②Use of TonoLab rebound tonometer: TonoLab rebound tonometer has two calibration modes for measuring mice and rats (Π=mouse, r=rat). When measuring, the rebound needle should be aimed at the center of the mouse / rat cornea, and the tonometer should be kept in a horizontal position and perpendicular to the surface of the mouse / rat cornea; Note that when holding the mouse / rat during the measurement, try to avoid applying pressure to its neck and eye socket, otherwise it will artificially cause an increase in intraocular pressure; After the mouse / rat is anesthetized by inhalation, the intraocular pressure is measured using the TonoLab rebound tonometer, and all intraocular pressure measurements are measured by the same operator in the same time period; TonoLab rebound tonometer can automatically calculate a complete measurement value by removing the highest and lowest values ​​of 6 consecutive measurements through the built-in software, and complete 5 complete measurements within 2 minutes after the mouse / rat loses consciousness, and then take the average of the 5 complete measurements as the final intraocular pressure value; ③ Time point of intraocular pressure measurement: The basic intraocular pressure measurement is before the first anterior chamber injection. The recommended measurement time is 8-10 am. The intraocular pressure is measured every other day after the anterior chamber injection. The anterior chamber injection is repeated every week during this period. After 4 weeks of monitoring, if the intraocular pressure rises steadily, the intraocular pressure can be monitored every other week. The modeling time lasts for 12 weeks. 2) Rabbit ① The intraocular pressure of the rabbit can be measured under topical anesthesia, and the rabbit box can be used to fix it for easy operation; ②Use of TonoVet rebound tonometer: TonoVet rebound tonometer is suitable for rabbits, cats, dogs, etc., and does not require manual calibration. When measuring, aim the rebound needle at the center of the rabbit cornea and keep the tonometer in a horizontal position while being perpendicular to the rabbit corneal surface. Note that if a rabbit box is used to fix it during the measurement, it should be avoided from getting stuck, otherwise it may cause increased intraocular pressure. The rest of the measurement process is the same as that of mice / rats. Step S3: After the high intraocular pressure model is successfully established, the eyeballs of the animals are taken to observe the angle opening, trabecular meshwork damage and retinal damage. After a group of experimental animals are killed at the end of the 4th week, the 8th week and the 12th week after the first intracameral injection, the eyeballs are taken for resin sectioning and hematoxylin-eosin staining (HE staining) to observe the angle opening, trabecular meshwork and retinal damage; after the isolated eyeballs are fixed, embedded, sectioned (mainly including angle trabecular meshwork sections and retinal sections), and HE staining, optical microscope is used to take pictures and observe to understand the angle opening, trabecular meshwork damage and retinal damage; Step S4: After the high intraocular pressure model is successfully established, the glaucomatous optic nerve damage is evaluated: A group of experimental animals were selected at the end of the 4th, 8th and 12th week after the first intracameral injection. Retinal flat-mounts were taken after perfusion and retinal ganglion cells (RGCs) were counted. The loss of RGCs was evaluated to understand the optic nerve damage in the high intraocular pressure animal model and verify whether it met the characteristic retinal damage of glaucoma. Step S5: Set up an intraocular pressure-lowering control group, and evaluate retinal damage after excluding factors affecting intraocular pressure to verify the effect of IFN-γ on intraocular pressure alone: The experimental animals were given anterior chamber injection of IFN-γ and intervention with hypotensive eye drops. 0.5% timolol maleate eye drops were used twice a day, 1 drop was administered through the conjunctival sac each time, at 9 am and 6 pm respectively, for 12 weeks. The intraocular pressure monitoring method and time point were the same as before (3.4), and the intraocular pressure was controlled at the baseline intraocular pressure, or the intraocular pressure fluctuation range was roughly the same as the intraocular injection of PBS control group, to exclude the direct damage of IFN-γ to retinal ganglion cells; from the same day of the first intracameral injection of IFN-γ, the animals were given hypotensive drugs. A group of experimental animals were killed at the end of the 4th week, the 8th week, and the 12th week respectively. The eyeballs were taken for resin sectioning and hematoxylin-eosin staining (HE staining), retinal flat mounts and RGCs counting (same method as before), to evaluate the full-thickness retinal damage and RGCs loss rate. The results were compared with the group that received intracameral injection of IFN-γ without intraocular pressure-lowering drug intervention. After excluding the factor of increased intraocular pressure caused by IFN-γ, the RGCs loss rate was significantly reduced, and no damage was found in the full-thickness retina, thereby verifying the effect of IFN-γ alone on intraocular pressure.

2. The method for constructing an open-angle glaucoma disease animal model according to claim 1, characterized in that: In step S3, taking mice as an example, the specific steps are as follows: ① Isolation of the retina after perfusion of mice: 1) Induce general anesthesia in mice by intraperitoneal injection of 1% sodium pentobarbital at a dose of 40-50 mg / kg, fix the mice on a foam board with needles (insert the limbs with needles), and spray the mouse hair with 75% alcohol; 2) Use forceps to lift the skin at the xiphoid process of the mouse, and use ophthalmic scissors to cut the skin and ribs of the chest to expose the heart and liver; 3) Use forceps to hold the mouse's heart apex, connect a 10ml needle to a syringe that absorbs 10ml of saline, and carefully insert it into the mouse's heart apex (be careful not to insert the needle too deep to prevent the liquid from being infused into the lungs). First, infuse a small amount of saline. After cutting the right atrial appendage with scissors in the left hand, infuse all the remaining saline. After the blood is drained, the limbs, liver, and tongue will turn white. 4) Keep the needle in the apex of the heart, remove the syringe, replace it with a syringe filled with 10ml 4% paraformaldehyde, and continue perfusion. When the paraformaldehyde flows to the brain, the mouse tail may have a slight reflex (sometimes there may be no reflex). At this time, the perfusion rate can be reduced to make the fixation more complete; (Fixation principle: paraformaldehyde can cross-link proteins); 5) Place the fixed mouse under a microscope and use forceps to remove the eyeball, being careful not to break it; 6) The intact eyeball was placed in an EP tube containing 4% paraformaldehyde and fixed at room temperature for 1 hour; 7) After puncturing the eyeball with a PP needle, use trabecular scissors to cut away the cornea and iris along the rupture, retain the lens, and continue to place it in an EP tube containing 4% paraformaldehyde for fixation at room temperature for 2-4 hours; 8) Remove the lens, hold the edge of the choroid with two forceps, carefully tear it apart to separate the choroid and retina, and continue to fix it in an EP tube containing 4% paraformaldehyde at 4 degrees overnight; ② Retinal flat mount and RGCs staining: 1) Place the retina in a 24-well plate and wash with PBST for 15 min x 3 times (shaking gently); 2) 50% methanol for 10 min (light shaking); 3) 100% methanol for 10 min (light shaking); 4) Wash with PBST for 15 min x 3 (shake gently); 5) Remove the retina, place it on a glass slide, and cut it into a four-leaf clover shape with a blade, so that it can be laid flat on the glass slide; 6) Blocking buffer (10 ml PBS + 1% BSA (0.1 g) + 0.5% Triton X-100 (50 ul)): room temperature, 60 min (gentle shaking); 7) Primary antibody RBPMS at 4°C overnight (protected from light); 8) Wash with PBST for 20 min x 4 (shake gently); 9) Secondary antibody at room temperature for 2 hours (protected from light); 10) Clip the retina and carefully flatten it on a glass slide. Add 1 drop of PBST to each retina to prevent it from drying. Hold your right hand with one finger and use tweezers in your right hand to remove iris fragments and other debris on the retina. Then use paper to absorb excess liquid from the retina. 11) Add anti-fluorescence quenching mounting medium, cover with coverslip, seal with nail polish and let dry, place paper on the surface of the slide, use a tip box to press a proper amount of water on the omentum for 0.5h, and store in a wet box; ③RGCs counting: Fluorescence microscopy was used to image, photograph and count RGCs. The mouse retinal flat mounts were divided into four quadrants: dorsal, ventral, nasal, and temporal. Two locations in each quadrant were selected for photography. ImageJ and ZEN image analysis software were used to count the RGCs in the photos, and the average count value was taken. The percentage of RGCs lost in the eyes injected with IFN-γ in the anterior chamber was calculated by comparing with the PBS control group.

3. The method for constructing an open-angle glaucoma disease animal model according to claim 1, characterized in that: In step S1, the animals were raised in a standard environment, with free access to water and food, and the experiment began after one week of adaptive feeding. The raising and operation strictly followed the ethical requirements for scientific research animals.

4. The method for constructing an open-angle glaucoma disease animal model according to claim 1, characterized in that: In step S2, the intraocular pressure is as follows: ① The basal intraocular pressure of mice before intracameral injection was 9.5±0.5 mmHg; ② After intracameral injection of IFN-γ, intraocular pressure gradually increases: C57BL / 6J mice were injected with IFN-γ (9000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice was monitored and it was significantly increased compared with the intraocular pressure of the control group from the 4th day after the first intracameral injection, which was statistically significant (P<0.05). It continued to rise steadily and reached a peak intraocular pressure level of 30.76±2.55mmHg about 35 days after modeling. The intraocular pressure was stably maintained around the peak value during the observation period of 35 to 90 days, which is a relatively ideal model of high intraocular pressure. C57BL / 6J mice were injected with IFN-γ (20000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice increased significantly from the second day after the first intracameral injection compared with the control group, with a statistically significant difference (P<0.05). The intraocular pressure reached a peak of 29.53±1.11mmHg on the 42nd day. The subsequent intraocular pressure values ​​were maintained around the peak value, which is a relatively ideal model of high intraocular pressure. C57BL / 6J mice were injected with IFN-γ (30000U / ml, repeated injection once a week) intracameral injection. The intraocular pressure of the mice was monitored and the intraocular pressure level could directly reach 23.84±0.41mmHg from the second day after the first intracameral injection. Compared with the intraocular pressure of the control group, it was significantly increased with statistical significance (P<0.0001). The intraocular pressure was stable at a high value from the second to the 90th day, and the highest value could reach 29.88±1.54mmHg, which is a relatively ideal model of high intraocular pressure. Openness of chamber angle and damage of trabecular meshwork: One group of mice were killed at the 4th, 8th and 12th week after the first intracameral injection, and the mouse eyeballs were taken for resin sectioning and hematoxylin-eosin staining (HE staining). Observation under an optical microscope showed that the chamber angle was open all around, which was consistent with the anatomical characteristics of open-angle glaucoma, and no obvious mechanical damage was found in the trabecular meshwork.

5. The method for constructing an open-angle glaucoma disease animal model according to claim 1, characterized in that: In step S4, the damage to the entire retina is as follows: At the end of the 4th, 8th, and 12th week after the first intracameral injection, mice were killed and their eyeballs were sliced ​​with resin and stained with hematoxylin-eosin (HE). Observation under an optical microscope revealed no obvious inflammatory damage in the entire retinal layer. The retinal ganglion cell counts were as follows: RGCs can be specifically marked by tissue immunofluorescence staining. A group of mice were selected at the end of the 4th, 8th and 12th week after the first intracameral injection. After perfusion, the retinal flat sections of both eyes were taken to count the retinal RGCs. The results showed that after 12 weeks of modeling, the number of RGCs in the intracameral injection of IFN-γ group was significantly reduced compared with the control group (P<0.05), indicating that the intracameral injection of IFN-γ can effectively induce increased intraocular pressure and glaucomatous optic nerve damage in mice.

6. The method for constructing an open-angle glaucoma disease animal model according to claim 1, characterized in that: In step S2, the direct effect of IFN-γ on the retina is evaluated after intravitreal injection: The experimental animals were injected with IFN-γ and PBS into the vitreous to evaluate the intraocular pressure and full-thickness retinal damage. The intravitreal injection was performed on the basis of pupil dilation. Because the mouse / rat lens occupies a large volume in the eye, attention should be paid to the inclination angle of the needle tip to avoid damaging the lens, retina and other intraocular tissues. To avoid acute increase in intraocular pressure, anterior chamber puncture can be performed before vitreous injection to release a small amount of aqueous humor. After injection, the needle stays in the vitreous for about 30 seconds, and then slowly withdraws the needle. When withdrawing the needle, the conjunctival incision can be closed with micro forceps to prevent leakage. The injection cycle is 12 weeks. A group of experimental animals were killed at the end of the 4th, 8th and 12th week, respectively. The eyeballs were sliced ​​and HE stained to evaluate the damage to the full-thickness retina caused by the direct action of IFN-γ on the retina.

Citation Information

Cited By

  • Construction method of intraocular hypertension animal model

    CN119969338A